Why the World Keeps Talking About 23andMe

Co-authored with Barbara Prainsack of the Department of Social Science, Health and Medicine, King's College London, UK Recent action by the FDA against the California-based personal genomics company 23andMe has sparked international attention and bemusement. While some observers agree with the FDA's insistence that the company stop marketing their tests until they have comprehensively backed up the validity of their health claims, to others, particularly outside the U.S., these developments seem...